A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumab

Milaan Shah; Mark Lebwohl

doi:10.1016/j.jaad.2024.12.042

A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumab

Milaan Shah
, Mark Lebwohl

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	1167-1169
Number of pages	3
Journal	Journal of the American Academy of Dermatology
Volume	92
Issue number	5
DOIs	https://doi.org/10.1016/j.jaad.2024.12.042
State	Published - May 2025

Keywords

REMS program
brodalumab
psoriasis
suicidality

Access to Document

10.1016/j.jaad.2024.12.042

Cite this

@article{1f53f7002b2742eda77144a48747bea2,

title = "A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumab",

keywords = "REMS program, brodalumab, psoriasis, suicidality",

author = "Milaan Shah and Mark Lebwohl",

year = "2025",

month = may,

doi = "10.1016/j.jaad.2024.12.042",

language = "English",

volume = "92",

pages = "1167--1169",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumab

AU - Shah, Milaan

AU - Lebwohl, Mark

PY - 2025/5

Y1 - 2025/5

KW - REMS program

KW - brodalumab

KW - psoriasis

KW - suicidality

UR - https://www.scopus.com/pages/publications/85217934560

U2 - 10.1016/j.jaad.2024.12.042

DO - 10.1016/j.jaad.2024.12.042

M3 - Article

C2 - 39863170

AN - SCOPUS:85217934560

SN - 0190-9622

VL - 92

SP - 1167

EP - 1169

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5

ER -